ORAL ETOPOSIDE IN THE TREATMENT OF CUTANEOUS LARGE-CELL LYMPHOMAS - A PRELIMINARY-REPORT OF 4 CASES
ORAL ETOPOSIDE IN THE TREATMENT OF CUTANEOUS LARGE-CELL LYMPHOMAS - A PRELIMINARY-REPORT OF 4 CASES
复制标题
DOI：
10.1111/j.1365-2133.1992.tb14853.x
复制
发表时间：
1992-11-01
影响因子：
10.3
通讯作者：
WILLEMZE, R
中科院分区：
文献类型：
--
作者：
RIJLAARSDAM, JU;HUIJGENS, PC;WILLEMZE, R
口服依托泊苷单药治疗4例皮肤淋巴瘤（非蕈样真菌病）的良好结果。在所有病例中，由于先前的化疗或患者的年龄，其他化疗选择受到限制。依托泊苷治疗导致所有患者最初完全缓解，并且副作用最小。
The favourable results of oral etoposide as single-agent therapy in four patients with a cutaneous lymphoma other than mycosis fungoides are reported. In all cases other chemotherapeutic options were limited because of prior chemotherapy or the age of the patients. Therapy with etoposide resulted in an initial complete remission in all patients, and was associated with minimal side-effects.